aMoon
Overview
aMoon is a global HealthTech and Life Sciences investment fund based in Israel. They partner with outstanding entrepreneurs who harness groundbreaking science and technology to transform healthcare, investing across all stages through three investment vehicles: aMoon Velocity, aMoon Growth, and aMoon Edge.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Lin Health | Dec 2025 | Series A | Co-investor |
| Adcytherix | Oct 2025 | Series A | Co-investor |
| Character Biosciences | Sep 2025 | Series B | Lead |
| Iantrek | Aug 2025 | Series C | Co-investor |
| Positive Development | Aug 2025 | Series C | Lead |
Key People
Marius Nacht
Co-Founder Anchor Investor
Yair Schindel
Co-Founder Managing Partner
Todd Sone
General Partner
Yaron Daniely
General Partner
Reut Shema
Managing Director
Barak Kariv
Venture Partner Head Of AMoon Insights
Samuel Moed
Venture Partner
Roy Wiesner
Partner
Yael Gruenbaum-Cohen
Partner Head Of AMoon Alpha
Ahuvit David
Principal
Patrick Rivers
Portfolio Manager
Adam Kotzen
Investor
Gaby Hirsch
VP Investor Relations And Communication
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.